RxDoctor Payments Data

Sergio Hurtado Cortes

Physician Assistant · Los Angeles, CANPI 1538631239

Payments from drug & device makers

$9,415in general payments, 2019–2025

Across 448 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$5K
  • Gilead$2K
  • Johnson & Johnson$307
  • Neurocrine Biosciences, Inc.$284
  • Amgen$267
  • EMD Serono, Inc.$184
  • plus $810 from 11 others

What the payments were for

  • Speaking & faculty fees$841%
  • Travel & lodging$190%
  • Food & beverage$9,31299%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,415 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala120$455,908
SerostimSomatropin14$279,592
MethitestMethyltestosterone14$84,626
DescovyEmtricitabine/Tenofov Alafenam37$79,953
DovatoDolutegravir Sodium/Lamivudine26$74,396
IsentressRaltegravir Potassium36$69,495
OdefseyEmtricitab/Rilpiviri/Tenof Ala12$43,705
TivicayDolutegravir Sodium12$41,664
TriumeqAbacavir/Dolutegravir/Lamivudi11$40,560
PifeltroDoravirine14$24,251
Maraviroc13$19,680
Etravirine12$12,102
MounjaroTirzepatide11$11,569
JardianceEmpagliflozin14$10,627
XyostedTestosterone Enanthate12$7,132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy$2,447$535,861157 claims
EMD Serono, Inc.Serostim$184$279,59214 claims
Viiv Healthcare CompanyDovato, Tivicay, Triumeq$5,115$156,62049 claims
MerckIsentress, Pifeltro$129$93,74750 claims
Lilly USA, LLCMounjaro$120$11,56911 claims
Antares Pharma, Inc.Xyosted$107$7,13212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →